title: Docetaxel. A review of its role in breast cancer treatment.
authors.affiliation: Service d'Oncologie Médicale, Hôpital La Salpêtriere, Paris, France.
authors.forename: E C
authors.initials: EC
authors.lastname: Antoine
authors.forename: O
authors.initials: O
authors.lastname: Rixe
authors.forename: G
authors.initials: G
authors.lastname: Auclerc
authors.forename: M
authors.initials: M
authors.lastname: Weil
authors.forename: D
authors.initials: D
authors.lastname: Khayat
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D000077143:Docetaxel; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012074:Remission Induction; D012449:Safety; D043823:Taxoids
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel